InvestorsHub Logo
Followers 2
Posts 13
Boards Moderated 0
Alias Born 04/20/2020

Re: None

Monday, 04/20/2020 11:23:40 AM

Monday, April 20, 2020 11:23:40 AM

Post# of 402729
Warning signs

1)The study identifying B as one of the few compounds out of 11000+ was published 4/12. The PR released this morning was on 4/20. This means that these results were likely out there in public or at least being used by Leo in his negotiations for 1-3 weeks. The fact that there are Still no deals is highly discouraging.

2) The next phase of B being studied at the RBL has not begun yet. Each day that goes by is critical as other drugs like Remdisivir may be approved and become the front line drug of choice. Given the urgency of this crisis one would think any potential promising drug would be moved along must faster as Large numbers of people continue to die.

3) The PR announcing discussions to advance B into human trials was 4/6. It is now 2 weeks later and nothing.

4) This statement from that same 4/6 PR “There can be no assurance that any trials for B will commence.”

5) IPIX market cap is 32M. That’s pocket change for Big Pharma if they’re looking to just buy it out for the rights to a potential game changing drug

6) Using the PR to solicit potential collaborations by saying please email us your inquiries?

I just don’t understand how a drug that defied incredible odds and is 1 of only 15 identified by the study out of 11,000+ as potentially being useful for The coronavirus has not gained incredible traction let alone its current status of next to zero traction.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News